We are live on ! Find out more

DSS Inc

DSS

Market cap $6.41M

0.6378 USD

-0.0122

1.88%

At close Updated Oct 2, 4:00 PM EDT

1 day

-1.88%

5 days

-6.96%

1 month

15.54%

3 months

4.69%

6 months

-31.79%

Year to date

-34.08%

1 year

-54.44%

5 years

-97.16%

10 years

-99.82%

About: DSS Inc is operating a business focused on four operating segments: Product Packaging, Biotechnology, Commercial Lending, and Securities and Investment Management. Currently operates five distinct business lines that operate around the globe with primary operations in North America and Asia. Product packaging manufactures and sells sophisticated custom folding cartons, mailers, photo sleeves, and complex three-dimensional direct mail solutions. The biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the Securities and Investment Management.

Employees: 102

Consumer Discretionary Packaging & Containers

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 100%

Negative 0%

DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical's Proposed Business Combination with Zoar Limited

ROCHESTER, N.Y., Sept. 16, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) (“DSS” or the “Company”) today announced that Zoar Limited (“Zoar” or “PubCo”) has filed a Registration Statement on Form F-4 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (“SEC”) in connection with the previously announced proposed business combination (the “Business Combination”) involving Impact Biomedical Inc. (NYSE American: IBO) (“Impact”), Zoar and certain related parties.

DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical's Proposed Business Combination with Zoar Limited

DSS, Inc. Launches DSS Robotics to Bring AI-Powered Automation to Enterprise Operations

New business will focus on practical robotics and intelligent automation solutions, with a planned Rochester innovation center for live deployments and customer demonstrations New business will focus on practical robotics and intelligent automation solutions, with a planned Rochester innovation center for live deployments and customer demonstrations

DSS, Inc. Launches DSS Robotics to Bring AI-Powered Automation to Enterprise Operations

DSS, Inc. Announces Decision Not to Proceed with Proposed Public Offering

NEW YORK, Sept. 04, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) (the “Company”), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending, and securities and investment management, today announced that after further consideration, the Company determined not to proceed with its previously announced proposed public offering of Common Stock due to the limited capacity available under its existing shelf registration statement.

DSS, Inc. Announces Decision Not to Proceed with Proposed Public Offering

DSS, Inc. Announces Launch of Proposed Public Offering

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE: DSS) (the “Company”), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending, and securities and investment management, today announced that it has commenced a public offering to offer and sell shares of its Common Stock.

DSS, Inc. Announces Launch of Proposed Public Offering

DSS, Inc. Withdraws Registration Statement

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) today announced that it has withdrawn its previously filed Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission. After careful review of current market conditions and deal terms, management and the Board of Directors concluded that proceeding with the offering at this time would not reflect the value DSS believes it is building for shareholders.

DSS, Inc. Withdraws Registration Statement

DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing

ROCHESTER, N.Y., May 08, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) announced that its annual report (10-K) for the fiscal year ending December 31, 2025, filed on March 31, 2026, includes an audit opinion from HTL International LLC. that contains a "going concern" qualification. This announcement is made pursuant to NYSE American LLC Company Guide Section 610(b), which requires public announcement of the receipt of an audit opinion containing a going concern paragraph and does not represent any change or amendment to the Company's financial statements for the year ended December 31, 2025.

DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing

DSS, Inc. Announces Closing of $1.0 Million Underwritten Public Offering

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) (the “Company”), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending, and securities and investment management, today announced the closing of its previously announced firm commitment underwritten public offering. Gross proceeds to the Company were approximately $1.0 million, before deducting underwriting fees and other offering expenses payable by the Company.

DSS, Inc. Announces Closing of $1.0 Million Underwritten Public Offering

DSS, Inc. Announces Pricing of $1.0 Million Underwritten Public Offering

NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE: DSS) (the “Company”), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending, and securities and investment management, today announced the pricing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be approximately $1.0 million, before deducting underwriting fees and other offering expenses payable by the Company.

DSS, Inc. Announces Pricing of $1.0 Million Underwritten Public Offering

DSS, Inc. Announces Launch of Proposed Public Offering

NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE: DSS) (the “Company”), a multinational company operating across diverse industries including packaging, wealth management, and biohealth innovation, today announced that it has commenced a public offering to offer and sell shares of its Common Stock.

DSS, Inc. Announces Launch of Proposed Public Offering

DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating across diverse industries including packaging, real estate, and biomedical innovation, today announced financial results for the first quarter of 2025, highlighting meaningful progress in its financial repositioning and a strong foundation for corporate execution in the coming quarters.

DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth

See News Rankings

Price charts implemented using Lightweight Charts™